Gut Inflammation
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
Probiotics Use and Preventing Gastrointestinal Symptoms in People Living With Overweight and Obesity.
Gut Organoid and Microbiome Interactions in Hypertension
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
Iron and Prebiotics Fortification in Kenyan Infants
A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Children